Shaperon
Business Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
174-10 Jagok-ro Gangnam-gu Ste 218 / 608...Website
www.shaperon.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Shaperon
Shaperon is a clinical-stage biotech company developing novel inflammasome inhibitors in the Republic of Korea. Its unique mechanism of action via GPCR19-P2X7 modulation suppresses a broad spectrum of inflammatory cytokines by controlling both priming and activation phase of inflammasome. Shaperon is engaged in multiple clinical programs in atopic dermatitis, COVID-19, Alzheimer's disease, idiopathic pulmonary fibrosis (IPF), ulcerative colitis, and NASH. Additionally, Shaperon is developing multi-valent and multi-specific nanobodies in oncology and viral infections.Explore more
Shaperon Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Shaperon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Shaperon has new funding data
Earning: See what the market has to say on Shaperon recently announced quarterly report
Check out if Shaperon is spiking on competitors!
Product Launch: Get notified when Shaperon launches new products
Check if Shaperon has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Shaperon, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Shaperon
Click to see if Shaperon had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Shaperon
Find 2 more new buyers
Company Profile Activity
Activity Insights
Shaperon is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Shaperon is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Shaperon.
Shaperon Tech Stack
A closer look at the technologies used by Shaperon
See more technologies
Shaperon News & Media
Hudson Therapeutics, the U.S. Subsidiary of Shaperon, Announces Initiation of Phase 2b Part 2 Clinical Trial for NuGel
DURHAM, N.C. & CAMBRIDGE, Mass. & SEOUL, South Korea--(BUSINESS WIRE)--Hudson Therapeutics, the U.S. subsidiary of Shaperon, announced today that Shaperon will commence the Phase 2b Part 2 of its clinical trial for NuGel, a first-in-class inflammasome inhibitor designed to treat mild to moderate atopic dermatitis. A kickoff meeting was recently held in March in the United States, marking a significant milestone in the global clinical development of NuGel. The clinical trial will be conducted acHudson Therapeutics and Shaperon Report Positive Result of Phase 2B Part 1 for Nugel at JPM 2025
DURHAM, NC, UNITED STATES, January 24, 2025 /EINPresswire.com/ -- Hudson Therapeutics and Shaperon announced on January 24th that they engaged in in-depth discussions about out-licensing their next-generation atopic dermatitis treatment, NuGel, with …Hudson Therapeutics Announces Completion of Phase 2b Part 1 Clinical Trial for Nugel
SAN FRANCISCO, CA, UNITED STATES, January 16, 2025 /EINPresswire.com/ -- Hudson Therapeutics, the U.S. subsidiary of Shaperon, announced the successful completion of Part 1 of the U.S. Phase 2b clinical trial for Nugel, the world’s first inflammatory …Hudson Therapeutics and Shaperon to Participate in Leading Major Global Biotech Conferences at the JPM Healthcare Week
DURHAM, NC, UNITED STATES, December 9, 2024 /EINPresswire.com/ -- Hudson Therapeutics, the US subsidiary of Shaperon, a leading innovator in therapeutic solutions, is excited to announce its participation in three major bio industry events during Bio …
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Shaperon
Sign Up For FreeTo access detailed company insights
Shaperon is a clinical-stage biotech company developing novel inflammasome inhibitors in the Republic of Korea. Its unique mechanism of action via GPCR19-P2X7 modulation suppresses a broad spectrum of inflammatory cytokines by controlling both priming and activation phase of inflammasome. Shaperon is engaged in multiple clinical programs in atopic... Read More
